BI-10773 (Empagliflozin) is a potent, highly selective SGLT2 inhibitor. It affects renal glucose reabsorption pathways by competitively blocking the sodium-glucose co-transporter 2 in the proximal tubule, promoting urinary glucose excretion and lowering blood glucose levels.
BI-10773 (Empagliflozin) IC50 for Cell-based and Cell-free Assays
Comprehensive IC50 Values for BI-10773 (Empagliflozin) Across Cell-free Enzyme Inhibitory Profiles and Cell-based Functional Assays.